nodes	percent_of_prediction	percent_of_DWPC	metapath
Amrinone—PDE3A—Nitric oxide stimulates guanylate cyclase—GUCY1A3—salivary gland cancer	0.106	0.106	CbGpPWpGaD
Amrinone—TNF—EV release from cardiac cells and their functional effects—MYB—salivary gland cancer	0.0996	0.0996	CbGpPWpGaD
Amrinone—TNF—Caspase Cascade in Apoptosis—GAS2—salivary gland cancer	0.0444	0.0444	CbGpPWpGaD
Amrinone—TNF—Canonical NF-kappaB pathway—CYLD—salivary gland cancer	0.0417	0.0417	CbGpPWpGaD
Amrinone—PDE3A—Platelet homeostasis—GUCY1A3—salivary gland cancer	0.0413	0.0413	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—IGFBP2—salivary gland cancer	0.0254	0.0254	CbGpPWpGaD
Amrinone—TNF—FAS pathway and Stress induction of HSP regulation—PRKDC—salivary gland cancer	0.0247	0.0247	CbGpPWpGaD
Amrinone—TNF—TNF receptor signaling pathway —CYLD—salivary gland cancer	0.0239	0.0239	CbGpPWpGaD
Amrinone—PDE3A—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0232	0.0232	CbGpPWpGaD
Amrinone—PDE4B—Myometrial Relaxation and Contraction Pathways—GUCY1A3—salivary gland cancer	0.0227	0.0227	CbGpPWpGaD
Amrinone—PDE4B—G alpha (s) signalling events—MC3R—salivary gland cancer	0.0221	0.0221	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—EN1—salivary gland cancer	0.0217	0.0217	CbGpPWpGaD
Amrinone—TNF—Apoptosis—GAS2—salivary gland cancer	0.0199	0.0199	CbGpPWpGaD
Amrinone—TNF—Cellular roles of Anthrax toxin—MAP2K2—salivary gland cancer	0.0198	0.0198	CbGpPWpGaD
Amrinone—TNF—Adipogenesis—WNT5B—salivary gland cancer	0.0168	0.0168	CbGpPWpGaD
Amrinone—TNF—Apoptosis—HIST1H1E—salivary gland cancer	0.0165	0.0165	CbGpPWpGaD
Amrinone—TNF—Canonical NF-kappaB pathway—ATM—salivary gland cancer	0.0163	0.0163	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—NUP62—salivary gland cancer	0.015	0.015	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—JMJD1C—salivary gland cancer	0.0144	0.0144	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—MAP2K2—salivary gland cancer	0.0128	0.0128	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—AQP1—salivary gland cancer	0.0125	0.0125	CbGpPWpGaD
Amrinone—TNF—Ceramide signaling pathway—MAP2K2—salivary gland cancer	0.0106	0.0106	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—CYLD—salivary gland cancer	0.00988	0.00988	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—VCAN—salivary gland cancer	0.0098	0.0098	CbGpPWpGaD
Amrinone—TNF—Apoptosis—DAPK1—salivary gland cancer	0.00974	0.00974	CbGpPWpGaD
Amrinone—TNF—Cardiac Hypertrophic Response—MAP2K2—salivary gland cancer	0.0095	0.0095	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—GUCY1A3—salivary gland cancer	0.00925	0.00925	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—GAS6—salivary gland cancer	0.00925	0.00925	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—MYB—salivary gland cancer	0.00831	0.00831	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—MAP2K2—salivary gland cancer	0.00821	0.00821	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—CREBBP—salivary gland cancer	0.00716	0.00716	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—MAP2K2—salivary gland cancer	0.00677	0.00677	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—FOXO3—salivary gland cancer	0.00631	0.00631	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—CNTN6—salivary gland cancer	0.00598	0.00598	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—CREBBP—salivary gland cancer	0.00582	0.00582	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—MAP2K2—salivary gland cancer	0.00579	0.00579	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TOP2A—salivary gland cancer	0.00557	0.00557	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor Pathway—EP300—salivary gland cancer	0.00554	0.00554	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—EP300—salivary gland cancer	0.00554	0.00554	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—MYB—salivary gland cancer	0.0055	0.0055	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—CREBBP—salivary gland cancer	0.00539	0.00539	CbGpPWpGaD
Amrinone—TNF—IL23-mediated signaling events—PIK3CA—salivary gland cancer	0.00488	0.00488	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—EP300—salivary gland cancer	0.00488	0.00488	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00487	0.00487	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—MC3R—salivary gland cancer	0.00477	0.00477	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—CREBBP—salivary gland cancer	0.00467	0.00467	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ERBB2IP—salivary gland cancer	0.00463	0.00463	CbGpPWpGaD
Amrinone—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—salivary gland cancer	0.00462	0.00462	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—MC3R—salivary gland cancer	0.00453	0.00453	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—MAP2K2—salivary gland cancer	0.00452	0.00452	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—BRCA1—salivary gland cancer	0.00445	0.00445	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—MC3R—salivary gland cancer	0.00433	0.00433	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—MC3R—salivary gland cancer	0.00412	0.00412	CbGpPWpGaD
Amrinone—TNF—Signaling events mediated by HDAC Class I—EP300—salivary gland cancer	0.00396	0.00396	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—MAP2K2—salivary gland cancer	0.00389	0.00389	CbGpPWpGaD
Amrinone—TNF—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—salivary gland cancer	0.00384	0.00384	CbGpPWpGaD
Amrinone—TNF—Aryl Hydrocarbon Receptor—HRAS—salivary gland cancer	0.00379	0.00379	CbGpPWpGaD
Amrinone—TNF—Transcriptional regulation of white adipocyte differentiation—EP300—salivary gland cancer	0.00367	0.00367	CbGpPWpGaD
Amrinone—PDE4B—G Protein Signaling Pathways—HRAS—salivary gland cancer	0.00349	0.00349	CbGpPWpGaD
Amrinone—TNF—TGF-beta Receptor Signaling—HRAS—salivary gland cancer	0.00334	0.00334	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—WNT5B—salivary gland cancer	0.00325	0.00325	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—IL17RD—salivary gland cancer	0.00314	0.00314	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—WNT5B—salivary gland cancer	0.00309	0.00309	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—CREBBP—salivary gland cancer	0.00306	0.00306	CbGpPWpGaD
Amrinone—TNF—Apoptosis—CDH1—salivary gland cancer	0.00306	0.00306	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—ATM—salivary gland cancer	0.003	0.003	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—IL17RD—salivary gland cancer	0.00298	0.00298	CbGpPWpGaD
Amrinone—TNF—Folate Metabolism—TP53—salivary gland cancer	0.00297	0.00297	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MAML3—salivary gland cancer	0.00287	0.00287	CbGpPWpGaD
Amrinone—TNF—Downstream signaling in naïve CD8+ T cells—HRAS—salivary gland cancer	0.00284	0.00284	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—CCND1—salivary gland cancer	0.00283	0.00283	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MAML3—salivary gland cancer	0.00273	0.00273	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CREBBP—salivary gland cancer	0.00261	0.00261	CbGpPWpGaD
Amrinone—TNF—Alzheimers Disease—TP53—salivary gland cancer	0.00257	0.00257	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MC3R—salivary gland cancer	0.00256	0.00256	CbGpPWpGaD
Amrinone—TNF—MicroRNAs in cardiomyocyte hypertrophy—PIK3CA—salivary gland cancer	0.00253	0.00253	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00246	0.00246	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—salivary gland cancer	0.00245	0.00245	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MC3R—salivary gland cancer	0.00243	0.00243	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—ST3GAL4—salivary gland cancer	0.00234	0.00234	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—DTX4—salivary gland cancer	0.00224	0.00224	CbGpPWpGaD
Amrinone—TNF—TNF alpha Signaling Pathway—HRAS—salivary gland cancer	0.00218	0.00218	CbGpPWpGaD
Amrinone—TNF—Toll-like Receptor Signaling Pathway—PIK3CA—salivary gland cancer	0.00217	0.00217	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—DTX4—salivary gland cancer	0.00213	0.00213	CbGpPWpGaD
Amrinone—TNF—SIDS Susceptibility Pathways—EP300—salivary gland cancer	0.00209	0.00209	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—CREBBP—salivary gland cancer	0.00203	0.00203	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—FOXO3—salivary gland cancer	0.00201	0.00201	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—CCND1—salivary gland cancer	0.00193	0.00193	CbGpPWpGaD
Amrinone—TNF—Spinal Cord Injury—TP53—salivary gland cancer	0.00187	0.00187	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—PTEN—salivary gland cancer	0.00186	0.00186	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FGF16—salivary gland cancer	0.00185	0.00185	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—EP300—salivary gland cancer	0.00177	0.00177	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FGF16—salivary gland cancer	0.00176	0.00176	CbGpPWpGaD
Amrinone—TNF—Regulation of toll-like receptor signaling pathway—PIK3CA—salivary gland cancer	0.00169	0.00169	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—MAP2K2—salivary gland cancer	0.00164	0.00164	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MAML2—salivary gland cancer	0.00161	0.00161	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00157	0.00157	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MAML2—salivary gland cancer	0.00153	0.00153	CbGpPWpGaD
Amrinone—TNF—Apoptosis—TP53—salivary gland cancer	0.0015	0.0015	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—MAP2K2—salivary gland cancer	0.00149	0.00149	CbGpPWpGaD
Amrinone—TNF—MAPK Signaling Pathway—TP53—salivary gland cancer	0.00141	0.00141	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—EP300—salivary gland cancer	0.00138	0.00138	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—JAG1—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FGFR4—salivary gland cancer	0.00137	0.00137	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—NOTCH1—salivary gland cancer	0.00134	0.00134	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FBXW7—salivary gland cancer	0.00134	0.00134	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—PIK3CA—salivary gland cancer	0.00131	0.00131	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—JAG1—salivary gland cancer	0.0013	0.0013	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FGFR4—salivary gland cancer	0.0013	0.0013	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FBXW7—salivary gland cancer	0.00128	0.00128	CbGpPWpGaD
Amrinone—TNF—Integrated Pancreatic Cancer Pathway—TP53—salivary gland cancer	0.00127	0.00127	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—CREBBP—salivary gland cancer	0.00122	0.00122	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—FOXO3—salivary gland cancer	0.00113	0.00113	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—FOXO3—salivary gland cancer	0.00108	0.00108	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—PIK3CA—salivary gland cancer	0.00102	0.00102	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—TP53—salivary gland cancer	0.000988	0.000988	CbGpPWpGaD
Amrinone—PDE3A—Hemostasis—HRAS—salivary gland cancer	0.000945	0.000945	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—MAP2K2—salivary gland cancer	0.000925	0.000925	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—MAP2K2—salivary gland cancer	0.00088	0.00088	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—EP300—salivary gland cancer	0.00083	0.00083	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—NOTCH1—salivary gland cancer	0.000758	0.000758	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—NOTCH1—salivary gland cancer	0.000721	0.000721	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CREBBP—salivary gland cancer	0.000687	0.000687	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CREBBP—salivary gland cancer	0.000654	0.000654	CbGpPWpGaD
Amrinone—PDE3A—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000646	0.000646	CbGpPWpGaD
Amrinone—PDE4B—GPCR downstream signaling—PIK3CA—salivary gland cancer	0.000614	0.000614	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000586	0.000586	CbGpPWpGaD
Amrinone—TNF—Developmental Biology—HRAS—salivary gland cancer	0.000568	0.000568	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—PIK3CA—salivary gland cancer	0.000558	0.000558	CbGpPWpGaD
Amrinone—PDE3A—Signaling by GPCR—HRAS—salivary gland cancer	0.000542	0.000542	CbGpPWpGaD
Amrinone—PDE4B—Signaling by GPCR—HRAS—salivary gland cancer	0.000516	0.000516	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—CCND1—salivary gland cancer	0.000509	0.000509	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PTEN—salivary gland cancer	0.000491	0.000491	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—CCND1—salivary gland cancer	0.000484	0.000484	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—EP300—salivary gland cancer	0.000468	0.000468	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PTEN—salivary gland cancer	0.000467	0.000467	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—EP300—salivary gland cancer	0.000445	0.000445	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—PIK3CA—salivary gland cancer	0.000346	0.000346	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—TP53—salivary gland cancer	0.000335	0.000335	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—PIK3CA—salivary gland cancer	0.000329	0.000329	CbGpPWpGaD
Amrinone—PDE3A—Signaling Pathways—HRAS—salivary gland cancer	0.00032	0.00032	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—TP53—salivary gland cancer	0.000319	0.000319	CbGpPWpGaD
Amrinone—PDE4B—Signaling Pathways—HRAS—salivary gland cancer	0.000305	0.000305	CbGpPWpGaD
